The Goldman Sachs Group Begins Coverage on Teladoc Health (NYSE:TDOC)

Equities researchers at The Goldman Sachs Group started coverage on shares of Teladoc Health (NYSE:TDOC) in a report issued on Friday,Benzinga reports. The brokerage set a “buy” rating and a $14.00 price target on the health services provider’s stock. The Goldman Sachs Group’s target price points to a potential upside of 56.25% from the stock’s previous close.

TDOC has been the topic of a number of other research reports. Piper Sandler lowered their price objective on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 6th. Barclays lifted their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Jefferies Financial Group increased their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Tuesday, September 17th. Finally, TD Cowen dropped their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Stock Down 6.4 %

TDOC opened at $8.96 on Friday. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $22.54. The stock has a market cap of $1.54 billion, a P/E ratio of -1.55 and a beta of 0.90. The stock’s 50 day moving average price is $8.86 and its 200 day moving average price is $9.44. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, research analysts predict that Teladoc Health will post -1.19 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO Mala Murthy sold 8,750 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the sale, the chief financial officer now owns 85,767 shares in the company, valued at $614,091.72. This represents a 9.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Thomas Mckinley acquired 4,000 shares of Teladoc Health stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $7.69 per share, with a total value of $30,760.00. Following the completion of the transaction, the director now directly owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 11.40 % increase in their position. The disclosure for this purchase can be found here. Insiders sold 20,051 shares of company stock valued at $143,565 over the last 90 days. 0.95% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently bought and sold shares of TDOC. Allspring Global Investments Holdings LLC raised its stake in Teladoc Health by 74.0% during the first quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock worth $311,000 after acquiring an additional 8,750 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Teladoc Health by 188.7% in the first quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock worth $477,000 after acquiring an additional 20,651 shares during the last quarter. Oppenheimer & Co. Inc. grew its stake in shares of Teladoc Health by 105.9% during the first quarter. Oppenheimer & Co. Inc. now owns 24,425 shares of the health services provider’s stock valued at $369,000 after purchasing an additional 12,561 shares during the last quarter. Swiss National Bank increased its holdings in shares of Teladoc Health by 0.6% in the first quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock valued at $4,936,000 after purchasing an additional 1,800 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System lifted its holdings in Teladoc Health by 2.2% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 173,878 shares of the health services provider’s stock worth $2,626,000 after buying an additional 3,777 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.